Drug to reverse fatty liver and atheromatous lesions

Details Drug to reverse fatty liver and atheromatous lesions Drug to reverse fatty liver and atheromatous lesions

1990-05-18

1992-05-12

Waddell, Frederick E.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

514824, 514838, A61K 3152

Patent

active

051128276

ABSTRACT:
The present invention comprises an amazingly effective method for the treatment, prevention and reversal of diet-induced high fat or alcohol-induced tissue-degernative conditions. More specifically, the present invention involves the discovery that pentoxidfylline, when administered in vivo will: (1) successfully treat diet-induced fatty liver conditions; (2) successfully treat atheromatous lesions, particularly those caused by ingestion of high levels of dietary fat and/or hypercholesterolemia; and (3) successfully treat conditions of fatty liver degeneration caused by chronic ingestion of ethanol or of toxic doses of various chlorinated hydrocarbons.

REFERENCES:
patent: 3737433 (1973-06-01), Moher et al.
patent: 4189469 (1980-02-01), Gleixner et al.
"Diagnosis and Treatment of Lower-Extremity Arteriosclerosis" Cleveland Clinic J Med 56(5): 467-468.
"Clinical Investigation of the Effects of Pentoxifylline in Patients Severe Peripheral Occlusive Vascular Disease". Curr med Res 2 Opin 9(97: 602-610).
Needleman et al (1985) Goodman and Gilman, eds., In: Pharmacological Basis of Therapeutics, 7th ed.
T. Rall (1985) Goodman and Gilman, eds., In: Pharmacological Basis of Therapeutics, Chapter 25, pp. 589-603.
Dialog Search (1990).
Granzer et al (1972) Arzeim-Forsch, 22(8): 1407-1410.
Brenner et tal (1967) Arzeim-Forsch, 17(8): 991-993.
Kuczynska et al (1988) Pol. Tyg. Lck., (Poland), 43(34): 1092-1094.
Sidorenko et al (1987) Kardiologiia, (USSR), 27(11): 77-80.
Gubski et al (1984).
Schaub et al (197) Munchener Medizinische Wochenschrift, Heft 26: 1265.
Nelemans (1972) Arzneim-Forsch (Drug Res), 220(8): 1410-1413.
Zeller et al (1966) Klin. Wschr., 44. Jahrg., Heft 17: 1022-1028.
Dettelbach et al (1985) J. Clin. Pharmacol., 25: 8-26.
Physician's Desk Reference (1989), pp. 1029-1030.
Brown et al (1985) Goodman and Gilman, eds., In: Pharmacological Basis of Therapeutics, 7th ed., pp. 827-845.

Affiliated with

Also associated with

Rating

Drug to reverse fatty liver and atheromatous lesions does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Drug to reverse fatty liver and atheromatous lesions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Drug to reverse fatty liver and atheromatous lesions will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2426186